Investigating the Hepatoprotective Properties of Entresto in Hepatic Ischemia‐Reperfusion Injury in Rats: The Implication of TLR4/MYD88/NF‐KB p‐65 and PPAR‐γ/HO‐1/Nrf2 Pathways
Archiv der Pharmazie · 2025-11 · 358 (11)
DOI: 10.1002/ardp.70138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 06.11.2025. Verfasst von Alaa Abouelhamd und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of pharmacy, Deraya University, New Minia City, Egypt. Hauptthemen laut MEDLINE: Reperfusion Injury, Protective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Hepatic ischemia/reperfusion injury (IRI) is a major complication during liver surgery, transplantation, and trauma. This study investigated the potential hepatoprotective effects of Entresto (sacubitril/valsartan), a dual angiotensin receptor‐neprilysin inhibitor, in a rat model of hepatic IRI. Male Wistar rats were pretreated with Entresto before 30 min of partial hepatic ischemia followed by 2 h of reperfusion. Serum liver enzymes (ALT, AST), oxidative stress markers (GSH, GSSG, GSH/GSSG ratio, MDA), and liver histopathology were assessed. Antioxidant and signaling proteins (CAT, SOD, GPx‐1, PPAR‐γ, HO‐1, Nrf2, IRAK‐M, GCL, NQO1) were determined by ELISA. qRT‐PCR assessed HO‐1, GCL, NQO1, GPx‐1, IL‐1β, IL‐6, TNF‐α, BAX, and BCL‐2 mRNA expression, while Western blot analysis analyzed TLR4, MyD88, and NF‐κB p65 protein expression. Entresto significantly reduced serum ALT and AST, MDA, and GSSG levels, while increasing GSH and restoring the GSH/GSSG ratio. Histopathology revealed notable restoration of the hepatic architecture. Entresto downregulated proinflammatory cytokines and apoptotic markers (BAX, caspase‐3), while upregulating antioxidant and antiapoptotic markers (PPAR‐γ, HO‐1, Nrf2, BCL‐2). Additionally, key proteins in the TLR4/MyD88/NF‐κB inflammatory pathway were significantly suppressed. These findings suggest that Entresto confers hepatoprotection against IRI by reducing oxidative stress, inflammation, and apoptosis, likely via modulation of TLR4/MyD88/NF‐κB and PPAR‐γ/Nrf2/HO‐1 signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of pharmacy, Deraya University, New Minia City, Egypt.
- Deraya Center for Scientific Research, Deraya University, New Minia City, Egypt.
- Department of Histology and Cell Biology, Faculty of Medicine, Minia University, Menia Governorate, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Minia University, 5Department of Biochemistry, Faculty of Pharmacy, Minia National Univeristy, New Minia, Egypt.
ORCID-Profile: Alaa Abouelhamd, Dalia H Abu-Baih
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Abouelhamd, A., Abu-Baih, D. H., Abdel-Hafez, S. M. N., & Fathy, M. (2025). Investigating the Hepatoprotective Properties of Entresto in Hepatic Ischemia‐Reperfusion Injury in Rats: The Implication of TLR4/MYD88/NF‐KB p‐65 and PPAR‐γ/HO‐1/Nrf2 Pathways. Archiv der Pharmazie, 358(11). https://doi.org/10.1002/ardp.70138
Vancouver
Abouelhamd A, Abu-Baih DH, Abdel-Hafez SMN, Fathy M. Investigating the Hepatoprotective Properties of Entresto in Hepatic Ischemia‐Reperfusion Injury in Rats: The Implication of TLR4/MYD88/NF‐KB p‐65 and PPAR‐γ/HO‐1/Nrf2 Pathways. Archiv der Pharmazie. 2025;358(11). doi:10.1002/ardp.70138
BibTeX
@article{Abouelhamd2025,
author = {Abouelhamd, Alaa and Abu-Baih, Dalia H and Abdel-Hafez, Sara Mohamed Naguib and Fathy, Moustafa},
title = {Investigating the Hepatoprotective Properties of Entresto in Hepatic Ischemia‐Reperfusion Injury in Rats: The Implication of TLR4/MYD88/NF‐KB p‐65 and PPAR‐γ/HO‐1/Nrf2 Pathways},
journal = {Archiv der Pharmazie},
year = {2025},
volume = {358},
number = {11},
doi = {10.1002/ardp.70138}
}
EUVIMED